Use of platelet glycoprotein IIb/IIIa inhibitors in diabetics undergoing PCI for non-ST-segment elevation acute coronary syndromes: impact of clinical status and procedural characteristics (Q33876187)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Use of platelet glycoprotein IIb/IIIa inhibitors in diabetics undergoing PCI for non-ST-segment elevation acute coronary syndromes: impact of clinical status and procedural characteristics	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Use of platelet glycoprotein IIb/IIIa inhibitors in diabetics undergoing PCI for non-ST-segment elevation acute coronary syndromes: impact of clinical status and procedural characteristics (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

acute coronary syndrome

1 reference

based on heuristic

inferred from title

object named as

William Wijns

10

0 references

Patrick W Serruys

7

object named as

Patrick Serruys

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Christian W Hamm

13

object named as

Christian W Hamm

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

6

object named as

Franz Eberli

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1

object named as

Timm Bauer

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Helge Möllmann

2

object named as

Helge Möllmann

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

4

object named as

Uwe Zeymer

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Ricardo Seabra Gomes

5

object named as

Ricardo Seabra-Gomes

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

9

object named as

Sigmund Silber

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Matthias Hochadel

11

object named as

Matthias Hochadel

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

12

object named as

Holger M Nef

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

15

object named as

Anselm K Gitt

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

8

object named as

Alec Vahanian

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Franz Weidinger

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Jean Marco

14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

26 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Clinical Research in Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

375-383

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

5 July 2018

Glycoprotein IIb/IIIa inhibitor-induced thrombocytopenia: diagnosis and treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

5 July 2018

Bivalirudin for patients with acute coronary syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

5 July 2018

Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

5 July 2018

Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

5 July 2018

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

5 July 2018

A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

5 July 2018

Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

5 July 2018

Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

5 July 2018

Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

5 July 2018

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

5 July 2018

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

5 July 2018

Interventional treatment in diabetics in the era of drug-eluting stents and compliance to the ESC guidelines: lessons learned from the Euro Heart Survey Programme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

29 October 2018

Early versus delayed, provisional eptifibatide in acute coronary syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

29 October 2018

Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocar

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

29 October 2018

Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

29 October 2018

The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

29 October 2018

Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

29 October 2018

Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

29 October 2018

Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

29 October 2018

Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

29 October 2018

Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1007%2FS00392-010-0130-1

21 January 2018

Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2876272

29 October 2018

Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20186546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20186546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20186546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20186546

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00392-010-0130-1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33876187&oldid=2195916072"